Literature DB >> 12543766

Severe interferon associated retinopathy.

K L Tu1, J Bowyer, K Schofield, S Harding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12543766      PMCID： PMC1771489          DOI： 10.1136/bjo.87.2.247

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Interferon-associated retinopathy and cystoid macular edema.

Authors:  R Tokai; T Ikeda; T Miyaura; K Sato
Journal:  Arch Ophthalmol       Date:  2001-07

Review 2.  Interferon associated retinopathy.

Authors:  S Hayasaka; Y Nagaki; M Matsumoto; S Sato
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

3.  Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1997-07

4.  Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  M Mauget-Faÿsse; C Chiquet; D Milea; P Romestaing; J P Gérard; P Martin; F Koenig
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

5.  Retinopathy associated with high-dose interferon alfa-2b therapy.

Authors:  C Hejny; P Sternberg; D H Lawson; K Greiner; T M Aaberg
Journal:  Am J Ophthalmol       Date:  2001-06       Impact factor: 5.258

6.  [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].

Authors:  S Soushi; F Kobayashi; H Obazawa; K Kigasawa; K Shiraishi; M Itakura; S Matsuzaki
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1996-01

7.  Interferon-associated retinopathy.

Authors:  D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal:  Arch Ophthalmol       Date:  1993-03

8.  Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation.

Authors:  H Nishiwaki; Y Ogura; K Miyamoto; N Matsuda; Y Honda
Journal:  Arch Ophthalmol       Date:  1996-06
  8 in total
  7 in total

1.  A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology.

Authors:  Meghan Berkenstock; Shaivi Patel; Jessica Ackert
Journal:  J Curr Ophthalmol       Date:  2020-04-30

Review 2.  Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.

Authors:  Ji-Hua Xue; Hai-Hong Zhu; Jing Wang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Interferon-alpha-associated presumed ocular sarcoidosis.

Authors:  Deshka Doycheva; Christoph Deuter; Nicole Stuebiger; Manfred Zierhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

4.  Is screening for interferon retinopathy in hepatitis C justified?

Authors:  F M Cuthbertson; M Davies; M McKibbin
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

5.  Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis.

Authors:  Hee Young Kang; Min Chul Shin
Journal:  Korean J Ophthalmol       Date:  2012-03-22

Review 6.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07

Review 7.  Role of interferons in diabetic retinopathy.

Authors:  Bing-Yan Li; Wei Tan; Jing-Ling Zou; Yan He; Shigeo Yoshida; Bing Jiang; Ye-Di Zhou
Journal:  World J Diabetes       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.